Skip to content
Screener

Price / earnings at other companies

Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
3.7×
AbbVie logo
AbbVieABBV
70.5×-16.6×

Other financials

Income statement

See full
Revenue$3.3B+12.5%
Gross profit$2.8B+11.2%
Operating income$1.2B+8.3%
Net income$1.1B+6.5%
EPS (diluted)$4.31+8.0%

Balance sheet

See full
Cash & equivalents$7.9B+57.6%
Total debt$2.0B+29.5%
Total equity$20.2B+17.9%
Total assets$27.4B+14.1%

Cash flow

See full
Operating cash flow$1.4B+74.4%
CapEx$133.4M+228%
Free cash flow$1.3B+66.4%

Valuation

See full
Market cap$121.09B-0.2%
Enterprise value$115.22B-2.2%
P/S9.6×-1.0×

Profitability

See full
Gross margin86%-0.1pp
Operating margin38%
Net margin35%
FCF margin30.4%+20.2pp

Returns & leverage

See full
Return on equity23.5%
Debt / equity0.1×0.0×
Current ratio3.2×+0.7×

Where this comes from

Calculated from Vertex Pharmaceuticals’s reported figures.

Based on the most recent quarter.

The source filing: Vertex Pharmaceuticals’s 8-K, filed August 3, 2026. Open the filing →

Filed
Aug 3, 2026, 4:09 PM EDT
Accession
0000875320-26-000256

FAQ

What is Vertex Pharmaceuticals's price / earnings?
Vertex Pharmaceuticals (VRTX) reported price / earnings of 28.6× in Q2 2026.
What is the long-term trend for Vertex Pharmaceuticals's price / earnings?
Over 4 years (2020 to 2025), Vertex Pharmaceuticals's price / earnings has grown at a 7.0% compound annual growth rate (CAGR), from 22.2× to 29.1×.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Ask your AI about Vertex Pharmaceuticals's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude